Impact Of A Pharmacological Cardioversion With Vernakalant On The Management Cost Of Recent Atrial Fibrillation In Belgium
Value Health
.
2014 Nov;17(7):A490.
doi: 10.1016/j.jval.2014.08.1447.
Epub 2014 Oct 26.
Authors
M Lamotte
1
,
L Gerlier
1
,
K Caekelbergh
1
,
K Lalji
2
,
J Polifka
2
,
E Lee
2
Affiliations
1
IMS Health HEOR, Vilvoorde, Belgium.
2
Cardiome Pharma Corp, Vancouver, BC, Canada.
PMID:
27201454
DOI:
10.1016/j.jval.2014.08.1447
No abstract available